Recent Articles
Can VEGFR Antibodies Become a Ne...
Th1/Th2 Subset Differentiation: ...
Paired Antibodies for Progestero...
Multiplex Cytokine Detection for Non-Human Primate Th1/Th2 and Inflammatory I...
Non-human primates serve as translational bridging preclinical immunology models with conserved Th1/Th2 signaling yet distinct cytokine transcription profiles vs humans; human ELISA reagents cause biased NHP data. ANT BIO’s S0Q1002...
Multiplex Cytokine Detection for Non-Human Primate Th1/Th2 and Inflammatory I...
Non-human primates serve as translational bridging preclinical immunology models with conserved Th1/Th2 signaling yet distinct cytokine transcription profiles vs humans; human ELISA reagents cause biased NHP data. ANT BIO’s S0Q1002...
Read More
T Cell Exhaustion: Core Immunosuppressive Barriers in Chronic Infection and T...
This article defines T cell exhaustion, covering core phenotypes, metabolic drivers including CHSY1/HIF1A and S1PR3-mediated tumor microenvironment immune suppression, plus combinatorial intervention targeting metabolism, cell cycle and immune checkpoints. ANT...
T Cell Exhaustion: Core Immunosuppressive Barriers in Chronic Infection and T...
This article defines T cell exhaustion, covering core phenotypes, metabolic drivers including CHSY1/HIF1A and S1PR3-mediated tumor microenvironment immune suppression, plus combinatorial intervention targeting metabolism, cell cycle and immune checkpoints. ANT...
Read More
c-Met Receptor Antibodies: Indispensable Research Tools for Oncogenic Signali...
Discover c-Met/HGF RTK structural features, widespread overexpression across solid tumors and core preclinical research challenges including therapeutic resistance and heterogeneous MET amplification. Compare anti-c-Met monoclonal antibodies versus small-molecule TKIs, covering...
c-Met Receptor Antibodies: Indispensable Research Tools for Oncogenic Signali...
Discover c-Met/HGF RTK structural features, widespread overexpression across solid tumors and core preclinical research challenges including therapeutic resistance and heterogeneous MET amplification. Compare anti-c-Met monoclonal antibodies versus small-molecule TKIs, covering...
Read More
Pan-Cytokeratin (CK-Pan) Antibodies: Core Research Tools for Epithelial Cytos...
Molecular Basis That Establishes CK-Pan Antibodies as Essential Cytoskeleton Probes Cytokeratins form a diverse subset of intermediate filament proteins that exclusively construct the core cytoskeletal scaffold within epithelial cell populations.Pan-cytokeratin...
Pan-Cytokeratin (CK-Pan) Antibodies: Core Research Tools for Epithelial Cytos...
Molecular Basis That Establishes CK-Pan Antibodies as Essential Cytoskeleton Probes Cytokeratins form a diverse subset of intermediate filament proteins that exclusively construct the core cytoskeletal scaffold within epithelial cell populations.Pan-cytokeratin...
Read More
Anti-CD146 Antibodies for Mechanistic Research of Lipid Metabolism and Energy...
Explore tissue-specific CD146 (MCAM) expression in adipose remodeling, covering ANGPTL2-CREB white adipogenic signaling and galectin-1-mediated suppression of brown fat UCP1 thermogenesis. CD146 drives lipid storage, adipocyte hypertrophy and low-grade inflammation...
Anti-CD146 Antibodies for Mechanistic Research of Lipid Metabolism and Energy...
Explore tissue-specific CD146 (MCAM) expression in adipose remodeling, covering ANGPTL2-CREB white adipogenic signaling and galectin-1-mediated suppression of brown fat UCP1 thermogenesis. CD146 drives lipid storage, adipocyte hypertrophy and low-grade inflammation...
Read More
Small-Molecule PITPNM3 Inhibitors: Mechanisms for Suppressing Tumor Metastasi...
Address key experimental hurdles in tumor metastasis research focusing on PITPNM3, a plasma membrane receptor activated by TAM-secreted CCL18 to drive PTK2B/EMT invasive signaling across breast, liver and pancreatic cancer....
Small-Molecule PITPNM3 Inhibitors: Mechanisms for Suppressing Tumor Metastasi...
Address key experimental hurdles in tumor metastasis research focusing on PITPNM3, a plasma membrane receptor activated by TAM-secreted CCL18 to drive PTK2B/EMT invasive signaling across breast, liver and pancreatic cancer....
Read More